1. Home
  2. CCG vs VNRX Comparison

CCG vs VNRX Comparison

Compare CCG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCG
  • VNRX
  • Stock Information
  • Founded
  • CCG 2014
  • VNRX N/A
  • Country
  • CCG China
  • VNRX United States
  • Employees
  • CCG N/A
  • VNRX N/A
  • Industry
  • CCG
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • CCG
  • VNRX Health Care
  • Exchange
  • CCG Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • CCG 63.4M
  • VNRX 52.4M
  • IPO Year
  • CCG N/A
  • VNRX N/A
  • Fundamental
  • Price
  • CCG $0.77
  • VNRX $0.64
  • Analyst Decision
  • CCG Buy
  • VNRX Strong Buy
  • Analyst Count
  • CCG 1
  • VNRX 5
  • Target Price
  • CCG $350.00
  • VNRX $3.88
  • AVG Volume (30 Days)
  • CCG 113.7K
  • VNRX 143.7K
  • Earning Date
  • CCG 08-28-2025
  • VNRX 08-18-2025
  • Dividend Yield
  • CCG N/A
  • VNRX N/A
  • EPS Growth
  • CCG N/A
  • VNRX N/A
  • EPS
  • CCG N/A
  • VNRX N/A
  • Revenue
  • CCG $475,831,129.00
  • VNRX $1,308,361.00
  • Revenue This Year
  • CCG N/A
  • VNRX $372.23
  • Revenue Next Year
  • CCG $7.06
  • VNRX $201.80
  • P/E Ratio
  • CCG N/A
  • VNRX N/A
  • Revenue Growth
  • CCG 5.20
  • VNRX 64.16
  • 52 Week Low
  • CCG $0.56
  • VNRX $0.40
  • 52 Week High
  • CCG $1.54
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • CCG 46.32
  • VNRX 44.71
  • Support Level
  • CCG $0.75
  • VNRX $0.60
  • Resistance Level
  • CCG $0.80
  • VNRX $0.80
  • Average True Range (ATR)
  • CCG 0.03
  • VNRX 0.05
  • MACD
  • CCG 0.00
  • VNRX -0.01
  • Stochastic Oscillator
  • CCG 30.34
  • VNRX 21.00

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: